JUNA
DEAD

Serial Number

98942613

Owner

Salk Health USA Inc.

Attorney

Seong-Cheol Son

First Use Date

Jan 30, 2023

Filing Date

Jan 7, 2025

Add to watchlist:

No watchlists yet
View on USPTO

JUNA Trademark

Serial Number: 98942613

JUNA is a trademark filed by Salk Health USA Inc. on January 7, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Salk Health USA Inc. (2 trademarks)

33 Henry Street
New York, NY 10002

Entity Type: 03

Trademark Details

Filing Date

January 7, 2025

Registration Date

Not Registered

First Use Anywhere

January 30, 2023

First Use in Commerce

January 30, 2023

Goods & Services

Telehealth care services; Mental health services; Health care services; Virtual health care services; Health care services, namely, health and wellness programs in the field of obesity; Health care services, namely, wellness programs; Health care services, namely, chronic care services; Health care services offered through a network of health care providers on a contract basis; Health care services in the field of sleeping disorders; Health care services in the field of sexual wellness; Health care services in the field of obesity; Providing health care via the internet; Providing health care via a website; Providing health care via a global computer network; Web-based health care services; Health care services, namely, integrated health care services with a network of health care providers; Providing information in the field of chronic health conditions via a website; Providing information in the field of general health and wellness via a website

Home testing apparatus for diagnosing human medical conditions, namely, test strips for measuring blood glucose levels; Home testing apparatus for diagnosing human diseases, namely, test strips for measuring blood glucose levels; Home testing apparatus for diagnosing sexually transmitted diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV; Home testing apparatus for diagnosing sexually transmitted infections, namely diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of HIV; Medical disease testing apparatus for home use, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, malaria; Medical disease testing apparatus for human medical conditions, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV and malaria; Medical disease testing apparatus for human diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of HIV and malaria; Medical disease testing apparatus for sexually transmitted diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of HIV; Medical disease testing apparatus for sexually transmitted infections, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of HIV; Medical diagnostic testing apparatus for home use, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV and malaria; Medical diagnostic testing apparatus for human medical conditions, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV and malaria; Medical diagnostic testing apparatus for human diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of HIV and malaria; Medical diagnostic testing apparatus for sexually transmitted diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of HIV; Medical diagnostic testing apparatus for sexually transmitted infections, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV; In vitro medical testing kits for home use, namely, ovulation test kits; In vitro medical testing kits for human medial conditions, namely ovulation test kits; In vitro medical testing kits for humans diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, malaria; In vitro medical testing kits for sexually transmitted diseases, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in HIV disease detection; In vitro medical testing kits for sexually transmitted infections, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 7, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 7, 2026 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2025 DOCK
ASSIGNED TO EXAMINER
Jun 17, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2025 NWOS
NEW APPLICATION ENTERED
Jan 7, 2025 NWAP